← Back to Home
Short Term·Markets Desk·Fri, 24 Jul
Mid-Horizon Plays: Analysts Identify 5 Stocks for Short-Term Gains
Research desks at Cnbc Awaaz and Sislofficial backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
By Markets Desk·9 Calls·6 Buy, 3 Sell
Cnbc Awaaz and 1 other registered desk issued 9 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a broadly bullish bias — 6 buys against 3 sells — covering 5 stocks.
TATACHEM attracted 2 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹683.8 targeting ₹1,000; Cnbc Awaaz issued a buy at ₹684.5 targeting ₹1,000.
FEDERALBNK attracted 4 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹352.75 (stop ₹320); Sislofficial issued a sell at ₹352 targeting ₹348 (stop ₹358); Sislofficial issued a sell at ₹352 targeting ₹345 (stop ₹358); Sislofficial issued a sell at ₹352 targeting ₹342 (stop ₹358).
AMBALALSA was flagged for a buy by Cnbc Awaaz at ₹31.89, targeting ₹1,109 — a potential upside of +3377.6%.
Also covered: LAURUSLABS (₹1,575 → ₹1,640) via Cnbc Awaaz; TITAN (₹4,675 → ₹4,850) via Cnbc Awaaz.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Analyst Sources
Cnbc AwaazSislofficial
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.